ClinicalTrials.govpublic full text
Optimal Haloperidol Dose for Postoperative Nausea and Vomiting Prevention in High-risk Patients
gynecological disease, non-smoker, female, iv pca, patient-controlled analgesia, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912491
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.